Impact of applying machine learning to the electronic medical record on prediction of cancer-associated thrombosis. Breakdown for provider order entry and pharmacist review with and without drug ...
“Tell me I’m okay”: A cross-sectional quality-of-life assessment of patients in a breast cancer survivorship program. This is an ASCO Meeting Abstract from the 2024 ASCO Quality Care Symposium. This ...
Improving distress screening in radiation oncology consultation. This is an ASCO Meeting Abstract from the 2024 ASCO Quality Care Symposium. This abstract does not include a full text component.
Qualitative acceptability testing of a paper-based care planner in patients with metastatic non-small cell lung cancer (mNSCLC). "We want that personal touch”: Dilemma of digitalization of healthcare ...
Understanding health literacy's moderating role in remote monitoring for adjuvant endocrine therapy: Findings from a randomized clinical trial. Associations of Medicaid expansion with stage at ...
Quality improvement scorecards driving innovation and best practice in a large community oncology practice.
Influence of an AYA cancer program on cancer care delivery.
Health-related quality of life of Canadian patients with human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer. US real-world utilization and outcomes of darolutamide, ...
The impact of oral oncology drugs in the era of value-based care. Median spending in 6 months after cancer diagnosis (in 2021 dollars), adjusted for age and sex.
Healthcare spending and out-of-pocket burden for working-aged adults after a cancer diagnosis.
Oncologists’ management of non-cancer conditions: An observational study.
Financial realities of fighting cancer: A close look at patient responsibility with part D coverage.
The cost of doing business: Drug costs in federally sponsored cancer clinical trials.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback